Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

To improve the prognosis of limited stage small cell lung cancer (LS-SCLC) the addition of concurrent thoracic radiotherapy to a platinum-containing regimen is important. In the Netherlands, we initiated a multicenter, phase II study, of the combination of four cycles of carboplatin (AUC 5), paclita...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Baas, P, Belderbos, J S A, Senan, S, Kwa, H B, van Bochove, A, van Tinteren, H, Burgers, J A, van Meerbeeck, J P
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2006
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361215/
https://ncbi.nlm.nih.gov/pubmed/16465191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602979
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars